241 related articles for article (PubMed ID: 17158542)
21. Staging refinements in renal cell carcinoma.
Howard GE; Wood CG
Curr Opin Urol; 2006 Sep; 16(5):317-20. PubMed ID: 16905974
[TBL] [Abstract][Full Text] [Related]
22. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes.
Pahernik S; Cudovic D; Roos F; Melchior SW; Thüroff JW
BJU Int; 2007 Jul; 100(1):26-9. PubMed ID: 17552949
[TBL] [Abstract][Full Text] [Related]
23. A new staging system for locally advanced (pT3-4) renal cell carcinoma: a multicenter European study including 2,000 patients.
Ficarra V; Galfano A; Guillé F; Schips L; Tostain J; Mejean A; Lang H; Mulders P; De La Taille A; Chautard D; Descotes JL; Cindolo L; Novara G; Rioux-Leclercq N; Zattoni F; Artibani W; Patard JJ
J Urol; 2007 Aug; 178(2):418-24; discussion 423-4. PubMed ID: 17561128
[TBL] [Abstract][Full Text] [Related]
24. Clinical outcome of surgical management for patients with renal cell carcinoma involving the inferior vena cava.
Terakawa T; Miyake H; Takenaka A; Hara I; Fujisawa M
Int J Urol; 2007 Sep; 14(9):781-4. PubMed ID: 17760741
[TBL] [Abstract][Full Text] [Related]
25. Does stage T3a renal cell carcinoma embrace a homogeneous group of patients?
Gofrit ON; Shapiro A; Pizov G; Landau EH; Katz R; Zorn KC; Pode D
J Urol; 2007 May; 177(5):1682-6. PubMed ID: 17437782
[TBL] [Abstract][Full Text] [Related]
26. [Renal-cell carcinoma. The basic concepts].
Reis M; Guimarães M
Acta Med Port; 1999; 12(1-3):81-5. PubMed ID: 10423878
[TBL] [Abstract][Full Text] [Related]
27. Surgical intervention in patients with metastatic renal cancer: current status of metastasectomy and cytoreductive nephrectomy.
Russo P
Nat Clin Pract Urol; 2004 Nov; 1(1):26-30. PubMed ID: 16474463
[TBL] [Abstract][Full Text] [Related]
28. [New trends in the diagnosis and treatment of renal cell carcinoma].
Zisman A
Harefuah; 2002 Aug; 141(8):713-7, 761. PubMed ID: 12222136
[TBL] [Abstract][Full Text] [Related]
29. Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy.
Klatte T; Seligson DB; LaRochelle J; Shuch B; Said JW; Riggs SB; Zomorodian N; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):894-900. PubMed ID: 19240241
[TBL] [Abstract][Full Text] [Related]
30. Reassessing the current UICC/AJCC TNM staging for renal cell carcinoma.
Moch H; Artibani W; Delahunt B; Ficarra V; Knuechel R; Montorsi F; Patard JJ; Stief CG; Sulser T; Wild PJ
Eur Urol; 2009 Oct; 56(4):636-43. PubMed ID: 19595500
[TBL] [Abstract][Full Text] [Related]
31. Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma.
Roos FC; Weirich J; Victor A; Elsässer A; Brenner W; Biesterfeld S; Hampel C; Thüroff JW
BJU Int; 2009 Aug; 104(4):461-9. PubMed ID: 19338563
[TBL] [Abstract][Full Text] [Related]
32. Significance of gene expression analysis of renal cell carcinoma.
Leppert JT; Pantuck AJ
Expert Rev Anticancer Ther; 2006 Feb; 6(2):293-9. PubMed ID: 16445381
[TBL] [Abstract][Full Text] [Related]
33. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.
Klatte T; Patard JJ; de Martino M; Bensalah K; Verhoest G; de la Taille A; Abbou CC; Allhoff EP; Carrieri G; Riggs SB; Kabbinavar FF; Belldegrun AS; Pantuck AJ
J Urol; 2008 May; 179(5):1719-26. PubMed ID: 18343437
[TBL] [Abstract][Full Text] [Related]
34. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M
J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725
[TBL] [Abstract][Full Text] [Related]
35. Advances in the staging of renal cell carcinoma.
Leung AC; Ghavamian R
Expert Rev Anticancer Ther; 2002 Dec; 2(6):673-80. PubMed ID: 12503213
[TBL] [Abstract][Full Text] [Related]
36. Nephron-sparing surgery versus radical nephrectomy in the treatment of intracapsular renal cell carcinoma up to 7cm.
Antonelli A; Cozzoli A; Nicolai M; Zani D; Zanotelli T; Perucchini L; Cunico SC; Simeone C
Eur Urol; 2008 Apr; 53(4):803-9. PubMed ID: 18036730
[TBL] [Abstract][Full Text] [Related]
37. The role of surgery in the management of early-stage renal cancer.
Russo P
Hematol Oncol Clin North Am; 2011 Aug; 25(4):737-52. PubMed ID: 21763965
[TBL] [Abstract][Full Text] [Related]
38. A review on follow-up strategies for renal cell carcinoma after nephrectomy.
Skolarikos A; Alivizatos G; Laguna P; de la Rosette J
Eur Urol; 2007 Jun; 51(6):1490-500; discussion 1501. PubMed ID: 17229521
[TBL] [Abstract][Full Text] [Related]
39. A review of prognostic pathologic features and algorithms for patients treated surgically for renal cell carcinoma.
Lohse CM; Cheville JC
Clin Lab Med; 2005 Jun; 25(2):433-64. PubMed ID: 15848745
[TBL] [Abstract][Full Text] [Related]
40. Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score.
Iimura Y; Saito K; Fujii Y; Kumagai J; Kawakami S; Komai Y; Yonese J; Fukui I; Kihara K
J Urol; 2009 Mar; 181(3):1004-12; discussion 1012. PubMed ID: 19150550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
